Upcoming Events

There are currently no events to display.

Past Events

Date Title
Mar 26, 2020 at
10:30 AM EDT 		Sol-Gel Technologies at 2020 Solebury Trout Virtual Investor Conference
Mar 04, 2020 at
10:40 AM EST 		Sol-Gel Technologies at Cowen and Company 40th Annual Health Care Conference

Supporting Materials
Jan 08, 2020 at
8:00 AM EST 		Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne

Supporting Materials
Nov 20, 2019 at
10:00 AM GMT 		Sol-Gel Technologies at Jefferies London Healthcare Conference

Supporting Materials
Nov 20, 2019 Sol-Gel at the Dermatology Drug Development Summit

Supporting Materials
Jul 25, 2019 at
8:30 AM EDT 		Sol-Gel Technologies Analyst and Investor Day

Supporting Materials
Jul 08, 2019 at
8:30 AM EDT 		Sol-Gel Announces Positive Topline Results from Phase 3 Program Evaluating Epsolay® for Moderate-to-Severe Rosacea

Supporting Materials
Jun 25, 2019 at
2:00 PM EDT 		Sol-Gel Technologies at BMO Prescription for Success Healthcare Conference
Jun 19, 2019 at
11:00 AM EDT 		Sol-Gel Technologies at JMP Life Science Conference

Supporting Materials
Jun 19, 2019 at
9:10 AM EDT 		Sol-Gel Technologies at Raymond James Life Science and MedTech Conference

Supporting Materials

Presentations

Date Title
March 4, 2020
Cowen and Company 40th Annual Health Care Conference
March 3, 2020
Sol-Gel Corporate Presentation
February 20, 2020
Sol-Gel Corporate Presentation
January 21, 2020
Twyneo® (Microencapsulated Benzoyl Peroxide 3%, Tretinoin 0.1%) Phase 3 Efficacy and Safety: Results from Two Randomized Controlled Clinical Trials
January 21, 2020
Characterization of Microencapsulated Benzoyl Peroxide (E-BPO) for the Treatment of Papulopustular Rosacea
January 21, 2020
Efficacy and Safety of Microencapsulated Benzoyl Peroxide (E-BPO) Cream, 5% in Papulopustular Rosacea: Results from Two Phase 3, Vehicle-Controlled Trials
January 13, 2020
Sol-Gel Corporate Presentation
January 8, 2020
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne
December 23, 2019
Sol-Gel Corporate Presentation
November 20, 2019
Dermatology Drug Development Summit
November 20, 2019
Jefferies London Healthcare Conference
July 25, 2019
Sol-Gel Technologies Analyst and Investor Day Presentation
July 8, 2019
Sol-Gel Announces Positive Top-Line Results from Epsolay® Phase 3 Program in Papulopustular Rosacea
June 19, 2019
Raymond James Life Science and MedTech Conference
June 19, 2019
JMP Life Science Conference
June 6, 2019
Jefferies Healthcare Conference
February 14, 2018
Sol-Gel’s Technology Presentation
February 14, 2018
TWIN Drug Product Candidate Presentation
February 14, 2018
VERED Drug Product Candidate Presentation